New onset type 2 diabetes mellitus risks with integrase strand transfer inhibitors-based regimens: A systematic review and meta-analysis

OBJECTIVES: The development of diabetes mellitus (DM) in patients taking integrase strand transfer inhibitors (INSTIs) has raised concerns. It's critical because, in most guidelines, INSTIs are the preferred third agent at first-line regimens. This study investigates the excess risk of developi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kajogoo, Violet Dismas, Amogne, Wondwossen, Medhin, Girmay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009287/
https://www.ncbi.nlm.nih.gov/pubmed/36923992
http://dx.doi.org/10.1016/j.metop.2023.100235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009287/
https://www.ncbi.nlm.nih.gov/pubmed/36923992
http://dx.doi.org/10.1016/j.metop.2023.100235

Ejemplares similares